Efficacy, Safety, Reactogenicity & Immunogenicity of the Rotarix Vaccine in Japanese Infants

NCT00480324 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

765

Enrollment

INDUSTRY

Sponsor class

Conditions

Infections, Rotavirus
Rotavirus Vaccines

Interventions

BIOLOGICAL: Rotarix
BIOLOGICAL: Placebo

Sponsor

GlaxoSmithKline